In our study, MPP+-treated SH-SY5Y neuronal cells were used as a PD model to evaluate the effects of MET and RAPA combinations on cell viability and an autophagy marker, LC3-II, including the autophagy-related Akt/S6K1 pathway. The gene discussed is RPS6KB1; the disease is Parkinson disease.